[1]
Nade, V. et al. 2026. In-Silico and In-Vivo Evaluation of Luteolin and Imeglimin as Novel Therapeutic Agents in Reserpine-Induced Parkinsons Disease in Rats: Neuroprotective effects of luteolin and Imeglimin in reserpine-induced Parkinsons disease in rats. Iranian Journal of Pharmaceutical Sciences. 22, 1 (Jun. 2026), 223–235. DOI:https://doi.org/10.22037/ijps.v22i1.50486.